CAP-7.1
CAP-7.1 is a DNA topoisomerase inhibitor investigated for its therapeutic potential in cancers such as biliary tract and non-small cell lung cancer. Research applications include in vitro studies on cancer cell lines and in vivo models to evaluate its antitumor efficacy and mechanism of action.
Product Specifications
CAS Number
433304-61-1
Smiles
O=C1[C@@]2 ([C@@H] (C=3C ([C@@H] (O[C@@H]4O[C@]5 ([C@] ([C@H] (O) [C@H]4O) (O[C@H] (C) OC5) [H]) [H]) [C@]2 (CO1) [H]) =CC6=C (C3) OCO6) C7=CC (OC) =C (OC (OCC8OC (C) (C) OC8) =O) C (OC) =C7) [H]
Molecular Formula
C36H42O17
Molecular Weight
746.71
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
More Discoveries
Explore Other Products
Browse additional items from our catalog
MBS1360565-01 0.02 mg (E-Coli)
Recombinant Erwinia carotovora subsp. atroseptica 3-ketoacyl-CoA thiolase (fadA)
Sign In for Pricing
View Details 
MBS1360565-02 0.02 mg (Yeast)
Recombinant Erwinia carotovora subsp. atroseptica 3-ketoacyl-CoA thiolase (fadA)
Sign In for Pricing
View Details MBS1360565-03 0.1 mg (E-Coli)
Recombinant Erwinia carotovora subsp. atroseptica 3-ketoacyl-CoA thiolase (fadA)
Sign In for Pricing
View Details 
MBS1360565-04 0.1 mg (Yeast)
Recombinant Erwinia carotovora subsp. atroseptica 3-ketoacyl-CoA thiolase (fadA)
Sign In for Pricing
View Details MBS1360565-05 0.02 mg (Baculovirus)
Recombinant Erwinia carotovora subsp. atroseptica 3-ketoacyl-CoA thiolase (fadA)
Sign In for Pricing
View Details MBS1360565-06 0.02 mg (Mammalian-Cell)
Recombinant Erwinia carotovora subsp. atroseptica 3-ketoacyl-CoA thiolase (fadA)
Sign In for Pricing
View Details